RNA-binding protein SAMD4A targets FGF2 to regulate cardiomyocyte lineage specification from human embryonic stem

Na Yi1,2,3, Han-Rui Wang1,2,3, Yu-Ping Zhu1,2,3

  • 1State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.

PubMed
Summary

SAMD4A, an RNA-binding protein, is crucial for heart development. It regulates cardiomyocyte lineage commitment by controlling FGF2 expression and AKT signaling, offering insights into congenital heart disease therapies.